Tenaya Therapeutics

171 Oyster Point Blvd
Suite 500
San Francisco
California
94080
United States

Show jobs for this employer

About Tenaya Therapeutics


Tenaya Therapeutics Inc. will build on discoveries in cardiovascular disease research made at the Gladstone Institutes, concentrating on regenerative medicine and drug discovery for heart failure. The new company combines Gladstone’s basic science expertise with the resources and translational know-how of the biotechnology industry.

YEAR FOUNDED:

September 19, 2016

LEADERSHIP:

Founders: Deepak Srivastava, Bruce Conklin, Benoit Bruneau and Saptarsi Haldar

6 articles with Tenaya Therapeutics